Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInsig Ai Plc Regulatory News (INSG)

Share Price Information for Insig Ai Plc (INSG)

Share Price is delayed by 15 minutes
Get Live Data
14.00    0.00 (0.00%)
Bid:
13.50
Ask:
14.50
Spread: 1.00 (7.407%)
Market Cap: £17.67m
INSG Live PriceLast checked at - London Stock Exchange

Intraday Insig Ai Plc Share Chart

Data partnership and research agreement

31 May 2022 07:00

RNS Number : 3156N
Insig AI Plc
31 May 2022
Β 

REACH

31 May 2022

Insig AI plc

("Insig AI" or the "Company")

Β 

Data partnership and research agreement with Blurred Global

to open up a new revenue channel

Β 

Insig AI plc (AIM: INSG), the data science and machine learning group, is pleased to announce that it has signed a data partnership and research agreement with Blurred Global ("Blurred") - a strategy advisor on ESG positioning and corporate communications.

Β 

Blurred is a team of ESG experts that work with FTSE 350 corporations on their purpose driven communication. Its work is built on the principles of ESGP, "because no organisation can have a credible, effective Purpose without first understanding the impact of its business on the Environment, on Society, and in terms of Governance."

Β 

Diana Rose, Head of ESG Research of Insig AI said: "We are excited to be providing FTSE350 and global corporate filings data to Blurred for the next year. Our goal at Insig AI is to provide the highest quality corporate disclosure data and NLP modules to enable great research teams to test their hypotheses, compare industry peers and track corporate ESG progress over time. Blurred is a leading voice in the ESG industry and we are eager to help it bring transparent and differentiated research to the market."

Β 

Colm McVeigh, Chief Executive of Insig AI commented: "This agreement now enables FTSE 350 constituents to access our machine learning corporate disclosure data. Importantly, this opens a potentially new revenue stream for our business."

Β 

Stuart Lambert, co-founder and Chief Strategy Officer at Blurred, said: "The area in which a company has the greatest potential to do harm is also the area in which it has the greatest potential to do good. We exist to help companies become fundamentally better, so that they then have a better story to tell, and then we tell that story to all audiences from investors to employees to customers. We're excited to be partnering with Insig AI to put its data science at the heart of the work we do for our clients."

Β 

This is a Reach announcement and the information contained is not considered to be material or to have a significant impact on management's expectations of the Company's performance. Reach is an investor communication service aimed at assisting listed companies to distribute non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

Β 

For further information, please visit www.insg.ai or contact:Β Β 

Insig AI plc

Colm McVeigh (CEO)

Via SEC Newgate

Zeus (Nominated Adviser & Broker)

David ForemanΒ /Β James HornigoldΒ /Β Danny Philips

+44 (0) 20 3829 5000

SEC Newgate (Financial Communications)

Robin Tozer / Richard Bicknell / Max Richardson

+44 (0) 7540 106 366

insigai@secnewgate.co.uk

About Blurred Global

Number 1 in PR Week's 2022 ESG rankings table. 2022 Best Consultancy to Work For, PRovoke Media. 2021 Specialist Consultancy of the Year, PR Week Awards. 2020 New Consultancy Of The Year, Global Sabre Awards & PR Week Awards

https://blurred.global/

Β 

Β 

About Insig AI

Insig AI is a data science and machine learning solutions company with a particular focus on the asset management industry. The Company's products are designed to adapt to and enhance investment strategies; enabling asset managers to transition to a data-centric business model, advance and scale their analytical potential and gain value, speed, and strategic leverage.

https://www.insg.ai/

Β 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word β€œReach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
NRABKKBNDBKBPPN
Date   Source Headline
1st Jun 20267:00 amRNSEquity subscription raising £0.2m and TVR
30th Apr 20267:00 amRNSNon-executive Directors’ Remuneration in Shares
22nd Apr 20267:00 amRNSEquity Subscription, TVR and PDMR Dealing
20th Apr 20267:00 amRNS-RCentral Bank MCP server in action
13th Apr 20267:00 amRNS-RLaunch of Central Bank Model Context Protocol
7th Apr 20267:01 amRNSHolding(s) in Company
7th Apr 20267:00 amRNSPDMR Dealings
1st Apr 20267:00 amRNSTrading update and potential NASDAQ listing
3rd Mar 20267:00 amRNSInsig AI contract win and revenue share agreement
28th Jan 20267:00 amRNSGrant of Share Options
28th Jan 20267:00 amRNSPDMR Dealing
27th Jan 20267:00 amRNSPDMR Dealing
11th Dec 20257:00 amRNSDirector Dealings
9th Dec 20257:00 amRNSInterim results
10th Nov 20257:00 amRNSNew contract with global advisory firm
29th Oct 20257:00 amRNS-RNew client win: new vertical market breakthrough
27th Oct 20257:00 amRNS-RMelloLondon Investor Event
16th Oct 20253:51 pmRNSResult of AGM
16th Oct 20257:00 amRNSTrading update & extended CLNs and warrant terms
8th Oct 202511:43 amRNSEquity fundraise
7th Oct 20257:00 amRNSEquity fundraise
1st Oct 20257:00 amRNSAppointment of Digital Asset Adviser
22nd Sep 20257:00 amRNSSubscription, Director Dealing & TVR
19th Sep 20257:00 amRNSFinal Results, Posting of AR&A and Notice of AGM
30th Jul 20257:00 amRNS-RLaunch of New Website and Corporate Brand Update
24th Jul 20257:00 amRNSDirector Dealing and Total Voting Rights
3rd Jul 20257:00 amRNSAppointment - Strategic & Asset Allocation Adviser
24th Jun 20257:05 amRNS-RAppointment of Business Development Director
24th Jun 20257:00 amRNSEquity Funding, Subscription, TVR & PDMR Dealing
6th Jun 20257:00 amRNSPDMR Dealings
20th May 20257:00 amRNS-RNew client win and additional sales prospects
12th May 20257:00 amRNS-RMello2025 Investor Event
8th May 20257:00 amRNS-RStrategic client win and new GIE product launch
6th May 20258:00 amRNS-RInsig AI & Falcon Windsor publish research re FTSE
29th Apr 20257:00 amRNSTrading Update and New Client Win
15th Apr 20257:00 amRNSPDMR Dealings
27th Mar 20257:00 amRNSPDMR Dealings
26th Mar 20257:00 amRNSPDMR Dealings
25th Mar 20257:00 amRNSPDMR Dealings
24th Mar 20257:03 amRNSTransfer of Share Options
24th Mar 20257:00 amRNSTrading Update, Equity Subscription, Funding & TVR
13th Mar 20257:00 amRNSNotice of Investor Presentation
3rd Mar 20259:21 amRNSReplacement: Change of website address
3rd Mar 20257:00 amRNSChange of website address
17th Feb 20257:00 amRNSNew Client Win and Revenue Share Partnership
19th Dec 20247:00 amRNSInterim Results
22nd Nov 20247:00 amRNSNew business win
11th Oct 20247:00 amRNSDirector Dealing
2nd Oct 202411:14 amRNSPDMR Dealing
30th Sep 20242:41 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.